OUR LAST PUBLICATIONS ABOUT PROSTATE CANCER

 1 – Primary Whole-gland Ablation for the Treatment of Clinically Localized ProstateCancer: A Focal Therapy Society Best Practice Statement.

Deivasigamani S, Kotamarti S, Rastinehad AR, Salas RS, de la Rosette JJMCH, Lepor H, Pinto P, Ahmed HU, Gill I, Klotz L, Taneja SS, Emberton M, Lawrentschuk N, Wysock J, Feller JF, Crouzet S, Kumar M P, Seguier D, Adams ES, Michael Z, Abreu A, Jack Tay K, Ward JF, Shinohara K, Katz AE, Villers A, Chin JL, Stricker PD, Baco E, Macek P, Ahmad AE, Chiu PKF, Crawford ED, Rogers CG, Futterer JJ, Rais-Bahrami S, Robertson CN, Hadaschik B, Marra G, Valerio M, Chong KT, Kasivisvanathan V, Tan WP, Lomas D, Walz J, Guimaraes GC, Mertziotis NI, Becher E, Finelli A, Kasraeian A, Lebastchi AH, Vora A, Rosen MA, Bakir B, Arcot R, Yee S, Netsch C, Meng X, de Reijke TM, Tan YG, Regusci S, Benjamin TGR, Olivares R, Noureldin M, Bianco FJ, Sivaraman A, Kim FJ, Given RW, Dason S, Sheetz TJ, Shoji S, Schulman A, Royce P, Shah TT, Scionti S, Salomon G, Laguna P, Tourinho-Barbosa R, Aminsharifi A, Cathelineau X, Gontero P, Stabile A, Grummet J, Ledbetter L, Graton M, Stephen Jones J, Polascik TJ; Focal Therapy Society.Eur Urol. 2023 Dec;84(6):547-560. doi: 10.1016/j.eururo.2023.06.013. Epub 2023 Jul 5.PMID: 37419773 Review.

2 – Biopsy strategies in the era of mpMRI: a comprehensive review.

Windisch O, Valerio M, Yee CH, Gontero P, Bakir B, Kastner C, Ahmed HU, De Nunzio C, de la Rosette J.Prostate Cancer Prostatic Dis. 2024 Sep 4. doi: 10.1038/s41391-024-00884-2. Online ahead of print.PMID: 39232094 Review.

3 – The role of T2-weighted images in assessing the grade of extraprostatic extension of the prostate carcinoma.

Onay A, Ertas G, Vural M, Colak E, Esen T, Bakir B.Abdom Radiol (NY). 2020 Oct;45(10):3293-3300. doi: 10.1007/s00261-020-02419-4.PMID: 32002569

4 – Correlation of SUV(max) and Apparent Diffusion Coefficient Values Detected by Ga-68 PSMA PET/MRI in Primary Prostate Lesions and Their Significance in Lymph Node Metastasis: Preliminary Results of an On-going Study.

Uslu-Beşli L, Bakır B, Asa S, Güner E, Demirdağ Ç, Şahin OE, Karayel E, Sağer MS, Sayman HB, Sönmezoğlu K.Mol Imaging Radionucl Ther. 2019 Sep 6;28(3):104-111. doi: 10.4274/mirt.galenos.2019.63825.PMID: 31507143 

5 – Hybrid Ga-68 prostate-specific membrane antigen PET/MRI in the detection of skeletal metastasis in patients with newly diagnosed prostate cancer: Contribution of each part to the diagnostic performance.

Asa S, Ozgur E, Uslu-Besli L, Ince B, Sager S, Demirdag C, Guner E, Sayman HB, Bakir B, Sonmezoglu K.Nucl Med Commun. 2023 Jan 1;44(1):65-73. doi: 10.1097/MNM.0000000000001637. Epub 2022 Nov 16.PMID: 36378618

6 – The Impact of Visible Tumor (PI-RADS 3) on Upgrading and Adverse Pathology at Radical Prostatectomy in Low Risk Prostate Cancer Patients: A Biopsy Core Based Analysis.

Özkan A, Köseoğlu E, Kılıç M, Baydar DE, Sağlıcan Y, Balbay MD, Canda AE, Kordan Y, Kiremit MC, Çil B, Tuğcu V, Bakır B, Esen T.Clin Genitourin Cancer. 2022 Feb;20(1):e61-e67. doi: 10.1016/j.clgc.2021.09.007. Epub 2021 Oct 9.PMID: 34750082

7 – Evaluation of the most optimal multiparametric magnetic resonance imaging sequence for determining pathological length of capsular contact.

Onay A, Vural M, Armutlu A, Ozel Yıldız S, Kiremit MC, Esen T, Bakır B.Eur J Radiol. 2019 Mar;112:192-199. doi: 10.1016/j.ejrad.2019.01.020. Epub 2019 Jan 22.PMID: 30777210

8 – Can Extraprostatic Extension Be Predicted by Tumor-Capsule Contact Length in Prostate Cancer? Relationship With International Society of Urological Pathology Grade Groups.

Bakir B, Onay A, Vural M, Armutlu A, Yıldız SÖ, Esen T.AJR Am J Roentgenol. 2020 Mar;214(3):588-596. doi: 10.2214/AJR.19.21828. Epub 2019 Oct 31.PMID: 31670596

9 – The relationship between amount of extra-prostatic extension and length of capsular contact: performances from MR images and radical prostatectomy specimens.

Onay A, Bakır B.Turk J Med Sci. 2021 Aug 30;51(4):1940-1952. doi: 10.3906/sag-2012-55.PMID: 33862674